DRMA Market Cap History Table | ||||||||||||||||||||||
Also see: DRMA Shares Outstanding History and DRMA YTD Return |
DRMA Market Cap History Table | ||||||||||||||||||||||
Also see: DRMA Shares Outstanding History and DRMA YTD Return |
DRMA Market Cap History Chart | ||||||||||||||||||||||||||||||
-69.89% CAGR Mouse over chart for data details
|
DRMA Stock Price Chart |
About Dermata Therapeutics Inc |
Dermata Therapeutics is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Co.'s main product candidate, DMT310, is intended to utilize its Spongilla technology for a once weekly treatment of a variety of skin diseases with its initial focus being for the treatment of acne vulgaris. Co.'s second product candidate utilizing its Spongilla technology is its combination treatment, DMT410. DMT410 is intended to consist of one treatment of Co.'s sponge powder followed by one topical application of botulinum toxin for delivery into the dermis. We show 10 historical shares outstanding datapoints in our DRMA shares outstanding history coverage, used to compute DRMA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DRMA market cap history over the course of time is important for investors interested in comparing DRMA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DRMA versus a peer is one thing; comparing DRMA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DRMA can fluctuate over the course of history. With this page we aim to empower investors researching DRMA by allowing them to research the DRMA market cap history. |
DRMA Current Stock Quote |
Free DRMA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
DRMA Share Performance |
Market Cap Peers |
Dermata Therapeutics (DRMA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
DRNA Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.